Hospitals & Diagnostics · Medical/Nursing Services · NSE: JSLL · data 2026-10-30
Jeena Sikho Lifecare Limited
In plain words
Price: 59.9% below its 52-week high of ₹835.
Delivery: 42.4% of traded shares were kept for delivery over the last 10 sessions, against 45.6% over the last 60.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹851 cr |
| Net profit (last 12 months) | ₹236 cr |
| Sales growth, 3 years (yearly) | 57.8% |
| Profit growth, 3 years (yearly) | 87.3% |
Smart-money activity
29/100 · Neutral over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 15/30: Delivery 41.7% over the last 20 sessions vs 45.8% in the 40 before (0.91x); shares delivered per day 1.7x usual; 2 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: Net −₹29.36 cr in bulk/block deals over 90 days (0 net buying days, 1 net selling day): more sold than bought.
- Insider / SAST buys 9/15: 0 insider buy days (promoter group among them) and 2 SAST acquisition days in 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Insider ● Deal ● Dividend
- 8 Oct 26Insider SAST disclosure: Bhavna Grover acquired 25,000 shares -7.7% next session
- 7 Oct 26Deal Bulk deal: OREGANO LIFE PRIVATE LIMITED sold ₹29.36 cr -13.6% next session
- 6 Oct 26Insider SAST disclosure: Bhavna Grover acquired 35,000 shares -7.3% next session
- 21 Sept 26Dividend Dividend ₹4.5 (ex-date) +1.0% next session
- 22 Sept 25Dividend Dividend ₹1.1 (ex-date) +1.6% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Common questions
Is Jeena Sikho Lifecare Limited debt-free?
Its latest reported debt-to-equity ratio is 0.27.
What is Jeena Sikho Lifecare Limited's P/E ratio?
About 17.6, based on the last 12 months' earnings and a price of ₹334.45 (data 2026-10-30).
What is the 52-week high and low of Jeena Sikho Lifecare Limited?
The 52-week high is ₹835 and the 52-week low is ₹328.8.
Similar companies
Metropolis Healthcare Ltd. (METROPOLIS) · Thyrocare Technologies Ltd (THYROCARE) · Nephrocare Health Services Limited (NEPHROPLUS) · Dr. Agarwal'S Eye Hospital Limited (DRAGARWQ) · Suraksha Diagnostic Ltd. (SURAKSHA)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open JSLL in NSE Scanner →